The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Abstract

PPMI has detailed the biomarker signature for an early PD cohort defined by clinical features and imaging biomarkers. This strategy provides the framework to establish biomarker cohorts and to define longitudinal progression biomarkers to support future PD treatment trials.